Sahlgrenska Acquires Second HoloMonitor System

After an initial purchase by Sahlgrenska University Hospital, Sahlgrenska Center for Cancer Research acquires a second HoloMonitor system. The fully equipped system was recently installed at the research center.

Within every cell in our body, there is a class of genes that controls cell growth. These genes are known as oncogenes. When an oncogene mutates, it can become hyper-activated and lead to uncontrolled cell division and tumors. In greater detail, the acquired HoloMonitor system will allow scientists at the cancer center to study the behavior of living cells and the effects of mutated oncogenes.

Man walking behind glass door next to a Sahlgren Academy poster

Sahlgrenska Center for Cancer Research is a joint effort between the Sahlgrenska Academy at the University of Gothenburg and the Sahlgrenska University Hospital. The center focuses on patient-centered research to improve cancer care by facilitating new scientific discoveries and translating these into clinical practice.

Phase Holographic Imaging PHI AB
Skiffervägen 48
224 78 Lund
Sweden
+46 46 38 60 80
info@phiab.se

Phase Holographic Imaging PHI Inc.
265 Franklin Street Suite 1702
Boston, MA 02110
USA
+1 617-963-5150
info@phiab.com

Invoicing

VAT: SE556542781101
faktura@phiab.se

Securities Identification

ISIN: SE0005504636
LEI: 549300JZR79QYESM6296

HoloMonitor® is a registered trademark
Copyright © 2012-2021
Phase Holographic Imaging PHI AB

Phase Holographic Image logo in white

PHI Theme 3.12.2